NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Sonnet BioTherapeutics Holdings Inc (NASDAQ: SONN)

 
SONN Technical Analysis
2.5
As on 9th Jun 2023 SONN STOCK Price closed @ 0.49 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.53 & Strong Buy for SHORT-TERM with Stoploss of 0.35 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

SONNSTOCK Price

Open 0.47 Change Price %
High 0.58 1 Day 0.00 0.00
Low 0.47 1 Week 0.06 13.95
Close 0.49 1 Month 0.24 96.00
Volume 4190100 1 Year 0.02 4.26
52 Week High 2.83 | 52 Week Low 0.20
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
SONN
Daily Charts
SONN
Intraday Charts
Whats New @
Bazaartrend
SONN
Free Analysis
 
SONN Important Levels Intraday
RESISTANCE0.70
RESISTANCE0.63
RESISTANCE0.59
RESISTANCE0.55
SUPPORT0.43
SUPPORT0.39
SUPPORT0.35
SUPPORT0.28
 
SONN Forecast May 2024
4th UP Forecast0.8
3rd UP Forecast0.7
2nd UP Forecast0.64
1st UP Forecast0.58
1st DOWN Forecast0.4
2nd DOWN Forecast0.34
3rd DOWN Forecast0.28
4th DOWN Forecast0.18
 
SONN Weekly Forecast
4th UP Forecast0.64
3rd UP Forecast0.59
2nd UP Forecast0.56
1st UP Forecast0.53
1st DOWN Forecast0.45
2nd DOWN Forecast0.42
3rd DOWN Forecast0.39
4th DOWN Forecast0.34
 
SONN Forecast2024
4th UP Forecast5.9
3rd UP Forecast4.17
2nd UP Forecast3.09
1st UP Forecast2.02
1st DOWN Forecast-1.04
2nd DOWN Forecast-2.11
3rd DOWN Forecast-3.19
4th DOWN Forecast-4.92
 
 
SONN Other Details
Segment EQ
Market Capital 37472116.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
SONN Address
SONN
 
SONN Latest News
 
Your Comments and Response on Sonnet BioTherapeutics Holdings Inc
 
SONN Business Profile
Sonnet BioTherapeutics Holdings, Inc., a clinical stage oncology-focused biotechnology company, develops platform for biologic medicines of single or bispecific action. The company develops fully human albumin binding technology, which utilizes human single chain antibodies fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. Its lead candidate is SON-1010, a fully human version of interleukin 12 for the treatment non-small cell lung cancer, and head and neck cancer. The company is also developing SON-080, a fully human version of interleukin 6 for chemotherapy-induced peripheral neuropathy and diabetic peripheral neuropathy. It has a license agreement with New Life Therapeutics PTE, LTD. to develop and commercialize pharmaceutical preparations containing a specific recombinant human interleukin 6. Sonnet BioTherapeutics Holdings, Inc. is based in Princeton, New Jersey. Address: 100 Overlook Center, Princeton, NJ, United States, 08540
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service